Incyte Corporation · NASDAQ:INCY
Stein Steven H sold 240,193 Incyte Corporation shares (Form 4)
Traded Nov 6, 2026 · Filed Nov 10, 2026
On Nov 6, 2026, Stein Steven H (CMO & Head of Late-Stage Dev.) sold 240,193 Incyte Corporation shares at an average US$118.39 for US$28.4M under a trading plan, leaving 30,916 shares. Filed Nov 10, 2026 (Form 4).
- Sold
- 240,193 shares
- Price
- US$118.39 average (US$116.06 to US$119.66)
- Value
- US$28.4M
- Holding after
- 30,916 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CMO & Head of Late-Stage Dev.
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | Common Stock | Option exercise | 8,539 | US$68.62 | 39,455 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 12,335 | US$72.27 | 51,790 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 16,428 | US$80.50 | 68,218 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 15,054 | US$74.78 | 83,272 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 23,526 | US$77.67 | 106,798 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 18,331 | US$61.76 | 125,129 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 19,749 | US$61.18 | 144,878 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 12,305 | US$64.25 | 157,183 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 6,907 | US$68.25 | 164,090 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 16,428 | US$85.01 | 180,518 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 12,743 | US$90.56 | 193,261 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 15,054 | US$83.58 | 208,315 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 24,838 | US$83.20 | 233,153 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 879 | US$113.64 | 234,032 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 17,986 | US$113.64 | 252,018 | Direct |
| Nov 6, 2026 | Common Stock | Option exercise | 19,091 | US$113.64 | 271,109 | Direct |
| Nov 6, 2026 | Common Stock | Sale | 35,042 | US$116.06 | 236,067 | Direct |
| Nov 6, 2026 | Common Stock | Sale | 22,336 | US$117.15 | 213,731 | Direct |
| Nov 6, 2026 | Common Stock | Sale | 60,270 | US$118.27 | 153,461 | Direct |
| Nov 6, 2026 | Common Stock | Sale | 73,969 | US$119.12 | 79,492 | Direct |
| Nov 6, 2026 | Common Stock | Sale | 48,576 | US$119.66 | 30,916 | Direct |
Source
Download original · View original at SEC
Related
- Incyte Corporation
- Stein Steven H
- Incyte Corporation shareholders
- Form 4 · Stein Steven H · Nov 18, 2026
- Form 4 · Stein Steven H · Jul 20, 2026
- Form 4 · Stein Steven H · Jul 16, 2026
- Form 4 · Stein Steven H · Jul 7, 2026
- Form 4/A · Stein Steven H · May 20, 2026
- Form 4 · Cagnoni Pablo J · Nov 18, 2026
- Form 4 · Heeson Lee · Nov 17, 2026
- Schedule 13G/A · Dodge & Cox · Nov 12, 2026
- Form 4 · Tray Thomas · Nov 5, 2026
- Form 4 · Cagnoni Pablo J · Oct 19, 2026